Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents

by Ciciola, Paola, Cascetta, Priscilla, Bianco, Cataldo, Formisano, Luigi, Bianco, Roberto
Published in J Clin Med (2020)

Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review

by Napolitano, Fabiana, Formisano, Luigi, Giardino, Alessandro, Girelli, Roberto, Servetto, Alberto, Santaniello, Antonio, Foschini, Francesca, Marciano, Roberta, Mozzillo, Eleonora, Carratù, Anna Chiara, Cascetta, Priscilla, De Placido, Pietro, De Placido, Sabino, Bianco, Roberto
Published in Cancers (Basel) (2019)

FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules

by Foschini, Francesca, Napolitano, Fabiana, Servetto, Alberto, Marciano, Roberta, Mozzillo, Eleonora, Carratù, Anna Chiara, Santaniello, Antonio, De Placido, Pietro, Cascetta, Priscilla, Butturini, Giovanni, Frigerio, Isabella, Regi, Paolo, Silvestris, Nicola, Delcuratolo, Sabina, Vasile, Enrico, Vivaldi, Caterina, Bianco, Cataldo, De Placido, Sabino, Formisano, Luigi, Bianco, Roberto
Published in Ther Adv Med Oncol (2020)

Everolimus induces Met inactivation by disrupting the FKBP12/Met complex

by Raimondo, Lucia, D'Amato, Valentina, Servetto, Alberto, Rosa, Roberta, Marciano, Roberta, Formisano, Luigi, Mauro, Concetta Di, Orsini, Roberta Clara, Cascetta, Priscilla, Ciciola, Paola, De Maio, Ana Paula, Di Renzo, Maria Flavia, Cosconati, Sandro, Bruno, Agostino, Randazzo, Antonio, Napolitano, Filomena, Montuori, Nunzia, Veneziani, Bianca Maria, Placido, Sabino De, Bianco, Roberto
Published in Oncotarget (2016)